Used as a diagnostic biomarker and a potential therapeutic target in HCC. Low expression of FTCD is closely related to the poor prognosis, alpha‐fetoprotein (AFP) level, larger tumour size and vascular invasion of HCC. Here, FTCD is linked to hepatocellular carcinoma.